Skip to content

Drug interactions

Lenacapavir + Vardenafil

Severity: Moderate

Lenacapavir and Vardenafil: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Lenacapavir is a moderate CYP3A inhibitor, and its long-acting subcutaneous form can affect CYP3A substrates for months. Vardenafil exposure may rise, increasing hypotension and QT risk.

What this interaction means in plain words

Lenacapavir and Vardenafil can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Lenacapavir belongs to Anti Virals; Vardenafil belongs to Genitourinary.

Evidence level: Moderate

Why it happens

Lenacapavir inhibits CYP3A4, decreasing vardenafil metabolism.

What to do

Use a reduced vardenafil dose and monitor blood pressure and adverse effects, including for months after the last subcutaneous lenacapavir dose.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Lenacapavir and Vardenafil, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Lenacapavir with Vardenafil?

MediHelp rates the interaction as moderate. Lenacapavir and Vardenafil can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Lenacapavir is a moderate CYP3A inhibitor, and its long-acting subcutaneous form can affect CYP3A substrates for months. Vardenafil exposure may rise, increasing hypotension and QT risk.

How serious is the interaction between Lenacapavir and Vardenafil?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Use a reduced vardenafil dose and monitor blood pressure and adverse effects, including for months after the last subcutaneous lenacapavir dose.

What other medicines interact with Vardenafil?

MediHelp also lists interactions of Vardenafil with, for example, Amyl nitrite, Glyceryl trinitrate pr, Isosorbide dinitrate. The full list is on the Vardenafil page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in